Charleston Neuroscience Institute — Ladson, South Carolina

Charleston Neuroscience Institute is a clinical research site located in Ladson, South Carolina, United States 29414.

Crixeo Clinical Trials Trust Score: 24/100 (FAILING). This profile has not yet been claimed by the site owner.

Charleston Neuroscience Institute has participated in 32 clinical trials with 8 currently active.

Therapeutic areas: Age-Related Macular Degeneration, Nonarteritic Anterior Ischemic Optic Neuropathy, Neovascular Age-related Macular Degeneration.

Sponsors: Samsung Bioepis Co., Ltd., Regenera Pharma Ltd, Ophthotech Corporation.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Ladson

Browse all research sites in South Carolina · View every site in Ladson

Sponsor Feasibility Report

Trust Score: 24/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Charleston Neuroscience Institute?

Charleston Neuroscience Institute has a Crixeo Trust Score of 24/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Charleston Neuroscience Institute conducted?

Charleston Neuroscience Institute has 32 clinical trials on record, with 8 currently active. Their work covers Age-Related Macular Degeneration, Nonarteritic Anterior Ischemic Optic Neuropathy, Neovascular Age-related Macular Degeneration.

Is Charleston Neuroscience Institute accredited by Crixeo Clinical Trials?

Charleston Neuroscience Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Charleston Neuroscience Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.